Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2025)
Historic Asset Utilization Ratio for Akebia Therapeutics (AKBA) over the last 9 years, with Q3 2025 value amounting to 0.63.
- Akebia Therapeutics' Asset Utilization Ratio rose 101911.99% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 101911.99%. This contributed to the annual value of 0.69 for FY2024, which is 197081.11% up from last year.
- Latest data reveals that Akebia Therapeutics reported Asset Utilization Ratio of 0.63 as of Q3 2025, which was up 101911.99% from 0.62 recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Asset Utilization Ratio ranged from a high of 0.85 in Q1 2023 and a low of 0.07 during Q3 2024
- Over the past 5 years, Akebia Therapeutics' median Asset Utilization Ratio value was 0.51 (recorded in 2022), while the average stood at 0.45.
- As far as peak fluctuations go, Akebia Therapeutics' Asset Utilization Ratio plummeted by 10868.21% in 2024, and later surged by 615401.74% in 2025.
- Akebia Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.37 in 2021, then surged by 81.92% to 0.68 in 2022, then plummeted by 93.83% to 0.04 in 2023, then surged by 1684.85% to 0.75 in 2024, then dropped by 15.3% to 0.63 in 2025.
- Its last three reported values are 0.63 in Q3 2025, 0.62 for Q2 2025, and 0.7 during Q1 2025.